Berbamine selectively induces apoptosis of human acute promyelocytic leukemia cells via survivin-mediated pathway

Chinese Medical Journal

Volumn 120, Issue 9, 2007, Pages 802-806

  Zhao, Xiao Ying ^a   He, Zhi Wen ^a   Wu, Dong ^a   Xu, Rong Zhen ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Acute promyelocytic leukemia; Apoptosis; Berbamine; NB4 cells; Survivin

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ARSENIC TRIOXIDE; BERBAMINE; CASPASE 3; MESSENGER RNA; PROMYELOCYTIC LEUKEMIA PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; SURVIVIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION;

EID: 34248638494     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200705010-00012     Document Type: Article

References (20)

1. Guo A, Salomoni P, Luo J, Shih A, Zhong S, Gu W, et al. The function of PML in p53-dependent apoptosis. Nat Cell Biol 2000; 2: 730-736.
2. de Stanchina, E, Querido E, Narita M, Davuluri RV, Pandolfi PP, Ferbeyre G, et al. PML is a direct p53 target that modulates p53 effector functions. Mol Cell 2004; 13: 523-535.
3. Salomoni P, Pandolfi PP. The role of PML in tumor suppression. Cell 2002; 108: 165-170.
4. 3 exerts dose-dependent dual effects on APL cells. Blood 1997; 89: 3345-3353.
5. Zhang TD, Chen GQ, Wang ZG, Wang ZY, Chen SJ, Chen Z. Arsenic trioxide, a therapeutic agent for APL. Oncogene 2001; 20: 7146-7153.
6. Shao W, Fanelli M, Ferrara FF, Riccioni R, Rosenauer A, Davison K, et al. Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells. J Natl Cancer Inst 1998; 90: 124-133.
7. Kai T, Kimura H, Shiga Y, Ogawa K, Sato H, Maruyama Y. Recurrent extramedullary relapse of acute promyelocytic leukemia after allogeneic stem cell transplantation: successful treatment by arsenic trioxide in combination with local radiotherapy. Int J Hematol 2006; 83: 337-340.
8. Gallagher RE, Schachter-Tokarz EL, Zhou DC, Ding W, Kim SH, Sankoorikal BJ, et al. Relapse of acute promyelocytic leukemia with PML-RARalpha mutant subclones independent of proximate all-trans retinoic acid selection pressure. Leukemia 2006; 20: 556-562.
9. de Botton S, Sanz MA, Chevret S, Dombret H, Martin G, Thomas X, et al. Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Leukemia 2006; 20: 35-41.
10. Xu R, Dong Q, Yu Y, Zhao XY, Gan XX, Wu D, et al. Berbamine: a novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity. Leuk Res 2006; 30: 17-23.
11. Sun JF, Zhang XH, He ZW, Gu Y, Yu YZ, Fang MY, et al. The mechanism of apoptosis chronic myeloid leukemia cells induced by the novel p210bcr/ ab1 inhibitor berbamine. Natl Med J China (Chin) 2006; 86: 2246-2251.
12. Xu R, Yu Y, Zheng S, Zhao XY, Dong QH, He ZW, et al. Overexpression of Shp2 tyrosine phosphatase is implicated in leukemogenesis in adult human leukemia. Blood 2005; 106: 3142-3149.
13. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462.
14. Schmitt CA, Lowe SW. Apoptosis and therapy. J Pathol 1999; 187: 127-137.
15. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998; 281: 1312-1316.
16. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391: 43-50.
17. Wolf BB, Schuler M, Echeverri F, Green DR. Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/ inhibitor of caspase-activated DNase inactivation. J Biol Chem 1999; 274: 30651-30656.
18. Xue J, Lin MF. Expression of survivin gene in NB4 cell line and cells of acute promyelocytic leukemia and its anti-apoptosis and clinical significance. Chin J Exp Clin Virol (Chin) 2006; 14: 332-336.
19. Moriai R, Asanuma K, Kobayashi D, Yajima T, Yagihashi A, Yamada M. Quantitative analysis of the anti-apoptotic gene survivin expression in malignant haematopoietic cells. Anticancer Res 2001; 21: 595-599.
20. Carter BZ, Miletla M, Altieri DC, Andreeff M. Cytokine-regulated expression of surviving in myeloid leukemia. Blood 2001; 97: 2784-2790.